Colorectal cancer treatment and research at The Royal Marsden Over 40,000 people are diagnosed with colorectal (bowel) cancer in the UK each year. This means that 1 in 14 men and 1 in 19 women will develop it at some point in their lifetime. Early diagnosis and treatment doubles the chance of survival. The Royal Marsden is internationally recognised as one of the leading centres in the world for pioneering cancer research and the development of new treatments. Since it opened in 1851 as the world’s first hospital dedicated to cancer, it has led the way in clinical research, developing the latest treatment options, accurate diagnosis and providing the best possible care for cancer patients. The hospital treats over 50,000 patients with cancer each year and is the only NHS Trust in the UK to receive a rating of double excellent for both service quality and use of resources for nine consecutive years by the Healthcare Commission and the Care Quality Commission. The Royal Marsden, in conjunction with The Institute of Cancer Research, is involved in pioneering clinical research for colorectal cancer and is one of the very few centres in the UK that treats patients with advanced colorectal cancers. It also specialises in treating patients with recurrent cancers (ones that have been operated on but have come back). They have a large, skilled and dedicated team that help and support every patient through the difficult cancer journey. In the past 40 years, the success of treatment has improved hugely with more people than ever surviving after having a diagnosis of colorectal cancer. This improvement is the result of decades of dedicated research across the world to help understand and treat it. Research has led to innovations in surgery in the form of new minimal access (keyhole) technologies such as laparoscopic and more recently, robotic surgery. This involves a highly precise surgical procedure following which patients make a quicker return to normal compared with the older, more invasive procedures. The Royal Marsden has been at the forefront of robotic cancer surgery and was the first centre in the UK to use the new da Vinci Xi robot to remove colorectal cancers. The Royal Marsden contributes regularly to the global body of knowledge and is conducting extensive research into ways to treat colorectal cancer, as well as other cancer types. Money raised will be spent directly on supporting research into colorectal cancer at The Royal Marsden and every penny will count. We need your help and support to make it all possible. Thank you.